varadi a
varadi a
hung* acad* sci* OR cornell OR eotvos OR res* center nat* sci*
Zweryfikowany adres z enzim.hu
Cytowane przez
Cytowane przez
Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system
B Sarkadi, L Homolya, G Szakács, A Váradi
Physiological reviews 86 (4), 1179-1236, 2006
An inventory of the human ABC proteins
I Klein, B Sarkadi, A Váradi
Biochimica et Biophysica Acta (BBA)-Biomembranes 1461 (2), 237-262, 1999
The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox)
G Szakács, A Váradi, C Özvegy-Laczka, B Sarkadi
Drug discovery today 13 (9-10), 379-393, 2008
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells
C Özvegy, T Litman, G Szakács, Z Nagy, S Bates, A Váradi, B Sarkadi
Biochemical and biophysical research communications 285 (1), 111-117, 2001
Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain
E Bakos, R Evers, G Szakács, GE Tusnády, E Welker, K Szabó, ...
Journal of Biological Chemistry 273 (48), 32167-32175, 1998
High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter
C Özvegy-Laczka, T Hegedűs, G Várady, O Ujhelly, JD Schuetz, A Varadi, ...
Molecular pharmacology 65 (6), 1485-1495, 2004
Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions
É Bakos, R Evers, E Sinkó, A Váradi, P Borst, B Sarkadi
Molecular pharmacology 57 (4), 760-768, 2000
ABCG2–a transporter for all seasons
B Sarkadi, C Özvegy-Laczka, K Német, A Váradi
FEBS letters 567 (1), 116-120, 2004
MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping
AJ Smith, A van Helvoort, G van Meer, K Szabó, E Welker, G Szakács, ...
Journal of Biological Chemistry 275 (31), 23530-23539, 2000
Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters
GE Tusnády, É Bakos, A Váradi, B Sarkadi
FEBS letters 402 (1), 1-3, 1997
Common evolutionary origin of the fibrin‐binding structures of fibronectin and tissue‐type plasminogen activator
L Bányai, A Váradi, L Patthy
FEBS letters 163 (1), 37-41, 1983
Molecular mechanisms of initiation of fibrinolysis by fibrin
L Medved, W Nieuwenhuizen
Thrombosis and haemostasis 89 (03), 409-419, 2003
Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6)
A Iliás, Z Urbán, TL Seidl, O Le Saux, E Sinkó, CD Boyd, B Sarkadi, ...
Journal of Biological Chemistry 277 (19), 16860-16867, 2002
The role of multidrug transporters in drug availability, metabolism and toxicity
A Bodó, É Bakos, F Szeri, A Váradi, B Sarkadi
Toxicology letters 140, 133-143, 2003
Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter: modulation of substrate specificity by a point mutation
C Ozvegy, A Váradi, B Sarkadi
Journal of Biological Chemistry 277 (50), 47980-47990, 2002
Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate
A Váradi, B Sarkadi
Biofactors 17 (1-4), 103-114, 2003
Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib)
NB Elkind, Z Szentpétery, Á Apáti, C Ozvegy-Laczka, G Várady, O Ujhelly, ...
Cancer research 65 (5), 1770-1777, 2005
ABCC6–mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation—brief report
RS Jansen, S Duijst, S Mahakena, D Sommer, F Szeri, A Váradi, A Plomp, ...
Arteriosclerosis, thrombosis, and vascular biology 34 (9), 1985-1989, 2014
Membrane Topology and Glycosylation of the Human Multidrug Resistance-associated Protein (∗)
E Bakos, T Hegedüs, Z Holló, E Welker, GE Tusnády, GJR Zaman, ...
Journal of Biological Chemistry 271 (21), 12322-12326, 1996
Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties
C Hegedűs, C Özvegy‐Laczka, A Apati, M Magocsi, K Nemet, L Őrfi, ...
British journal of pharmacology 158 (4), 1153-1164, 2009
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20